Pfizer Ltd

Information

Name

Pfizer Ltd

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

https://etendersni.gov.uk/epps

Address

Tadworth

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Pfizer Ltd
Sign up free

Contracts awarded to Pfizer Ltd

The contracts that Pfizer Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 14 hours ago

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

£4,108,145,000 Bids close: 3 months ago
Award

Published 14 hours ago

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026

£24
Award

Published 5 days ago

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

£261,895,933 Bids close: 4 months ago
Award

Published 5 days ago

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines – Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026

£29
Award

Published 1 month ago

Medicinal Products and Pharma Funded Homecare [5749446]

Medicinal Products and Pharma Funded Homecare

£384,000,000
Award

Published 2 months ago

Biologic and Biosimilar Medicines

Biologic and Biosimilar Medicines

£96,642,400

Contacts

+44 7471112086

[email protected]

Statistics (1 Year)

Contracts Won

Total Won

£571,078,052

Average Win

£57,107,805

Pfizer Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Pfizer Ltd

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025

Medicinal Products and Pharma Funded Homecare [5749446]

Biologic and Biosimilar Medicines

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win